To see the effect of some ayurveda drugs in Amlapitta associated with Sleep disturbance.

A Survey Study to Find out the Relation between Sleep and Amlapitta (Hyperacidity) and Therapeutic Trial of Jatamansi Phanta, Dhanyaka Hima and Kamdugha Rasa

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2018/10/016162

Enrollment

100

Registered

2018-10-25

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K30- Functional dyspepsia Health Condition 2: K318- Other specified diseases of stomach and duodenum

Interventions

Intervention1: KAMDUGHA RASA: DOSE-250 mg BD ORALLY WITH DHANYAKA HIM OR JATAMANSI PHANTA FOR 21 DAYS Control Intervention1: DHANYAKA HIMA: DOSE-100 ml BD ORALLY WITH KAMDUGHA RASA-250 mg FOR 21 DAYS

Eligibility

Inclusion criteria

Inclusion criteria: A. PATIENTS AGE BETWEEN 15 YEARS AND 75 YEARS OF BOTH SEXES. B. THE PATIENTS WITH GENERAL FEATURES OF AMLAPITTA ASSOCIATED WITH ANIDRA - SUCH AS AVIPAKA, KLAMA, HRIDDAHA,.KANTHADAHA, AMLODGARA, GAURAV,UTKLESHA, TIKTODGARA,ARUCHI,ANGAMRDA, SHIROGAURAV, JRAMBHIKA, JADYA , GLANI, BHRMA ,APKTI, TANDRA,ANGAMRDA, SHIROGAURAV, JRAMBHIKA, JADYA , GLANI, BHRMA ,APKTI, TANDRA ETC.

Exclusion criteria

Exclusion criteria: A. PATIENTS AGE BELOW 15 YEARS AND ABOVE 75 YEARS. B. SEVERELY MALNOURISHED AND DEBILITATED PATIENTS. C. PATIENTS SUFFERING FROM PEPTIC ULCERS WITH MALIGNANCY. D. PATIENTS SUFFERING FROM DIABETES MELLITUS AND OTHER CHRONIC DISORDERS. E. PATIENTS OF AMLAPITTA WITHOUT ANIDRA. F. PATIENTS ASSOCIATED WITH ANY OTHER SERIOUS SYSTEMIC DISEASE OR COMPLICATIONS.

Design outcomes

Primary

Measure	Time frame
patients of both sexes age group 15 to 75 years of Amlapitta will be selected for relieving sign and symptomsTimepoint: patients of both sexes age group 15 to 75 years of Amlapitta will be selected for relieving sign and symptoms	—

Secondary

Measure	Time frame
Assess the comparative efficacy between Kamdugha rasa with dhanyaka hima and Jatamaansi phanta after 3 weeks in case of AmlapittaTimepoint: Assess the comparative efficacy between Kamdugha rasa with dhanyaka hima and Jatamaansi phanta after 3 weeks in case of Amlapitta	—

Countries

India

Contacts

Public ContactDR BALKRISHAN SEVATKAR

NATIONAL INSTITUTE OF AYURVEDA,JAIPUR

DRBKS6@GMAIL.COM9352311105

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026